首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
首頁 > 市場調查報告書 > 生物科技 > 再生醫學 > 生物技術的培養基、血清與試劑市場
產業/市場分類
生物科技 (1574)
分子標靶治療學 (131)
生技設備 (354)
生物材料 (53)
生物標記 (155)
以基因為基之藥物開發 (202)
再生醫學 (119)
抗體和免疫 (189)
個人化醫學 (51)
基因治療學和RNAi (102)
市場調查報告書

生物技術的培養基、血清與試劑市場

The Dynamic Media, Sera and Reagent Market in Biotechnology

出版商 BCC Research
出版日期 2010年07月 商品編碼 125938
內容資訊 英文 143 Pages
價格
本報告書已不再販售

本報告已在2012年04月13日停止出版。

更改為出版

全球生物科技部門中的培地・血清・試藥市場
Global Markets for Media, Sera and Reagents in Biotechnology
出版日期 : 2012年04月
商品編碼: 237066

簡介

2010年全球生物技術的培養基、血清與試劑市場的業績達到25億4,620萬美金。預測未來將以8.7%的CAGR持續成長，並於2015年超越38億美金。

本報告書提供培養基、血清、試劑市場的概要與技術動態介紹，並彙整了各國的規範概要、專利與終端用戶之動態，以及主要企業的簡介等資訊，內容概要摘記如下。

第1章 導論

第2章 重點摘要

第3章 概要

  • 細胞培養技術的產品
  • 細胞培養的種類
  • 細胞培養基的功能
  • 細胞培養基的種類
  • 為何使用無血清培養基
  • 血清

第4章 法規之相關課題

  • 許可
  • 撤銷
  • 生技製藥管理措施
  • 療效

第5章 業界結構

  • 生物技術所使用的培養基、血清、試劑之製造業者／產品
  • 業界領導的市佔率

第6章 新技術

  • 新興技術

第7章 市場

  • 培養基
    • 市場概要
    • 市場收益
    • 市場佔有率
    • 無血清培養基與血清培養基
    • 粉末培養基與液態培養基
    • 既有與特殊培養基
  • 血清
    • 市場概要
    • 市場收益
    • 市場佔有率
  • 試劑
    • 市場概要
    • 市場收益
    • 市場佔有率

第8章 終端用戶

  • 各種應用的市佔率
    • 研究分類
    • 生產分類
    • 委託分類
    • 其他分類

第9章 專利分析

第10章 目前的市場環境

  • 細胞培養產品市場的主要企業
  • 影響培養基、血清、試劑市場的因素
  • 未來的細胞培養市場

第11章 企業簡介

附錄

圖表

目錄

Abstract

HIGHLIGHTS:

THIS REPORT CONTAINS
  • Total worldwide sales revenues for media, sera, and reagent used in the biotechnology were $2,546.2million in 2010, and are expected to increase to more than $3800 Million in 2015, at a compound annual growth rate (CAGR) of 8.7%.
  • The largest biotechnology segments in 2010 were Reagents. All Reagents in Biotechnology will increase from $1,066.6 million in 2010 to nearly $1,850.4 million in 2015, at a compound annual growth rate (CAGR) of 11.6%.
  • Sales of Media will experience high growth. This market segment was worth $821.8 million in 2010 and will increase at a 8.6% compound annual growth rate (CAGR) to reach a value of $1,242.4 million in 2015.
  • Sales of Sera will experience moderate growth. This market segment was worth $31657.8 million in 2010 and will increase at a 3.3% compound annual growth rate (CAGR) to reach a value of $772.5 million in 2015.

SCOPE AND ANALYST

STUDY OBJECTIVES

BCC's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for media, sera, and reagents used in biotechnology. The key objective is to present a comprehensive analysis of the current market and its future direction for the next 5 years. The improvisation of the market, the setbacks, and the needs of the market are discussed in this report. The types of cell culture and the products from cell culture technology are also portrayed. Also covered are the advantages and disadvantages of the use of various types of media. A detailed analysis of the structure of the cell culture industry has been conducted. This includes the biotechnology reagents, media, and the sera used. Revenues are broken down by region. Sales figures are estimated for the 5-year period from 2010 through 2015. Applications for the cell culture industry - media, sera, and reagents used in biotechnology - are also discussed separately, with an emphasis on the usage in the research, production, and contract segments. This report also covers significant patents and their allotments in each category.

REASONS FOR DOING THIS STUDY

Demand for cell culture products, namely, media, sera, and reagents, is increasing with the increasing demand for biopharmaceuticals. Cell culture, a crucial component of the life-sciences industry has witnessed major developments in the past three decades. Research and development (R&D) spending, along with increasing competition, patent expiries, new technologies, and an international marketplace are pointing this market in a new direction. During the evolution of cell culture technologies, a number of disciplines, such as cell biology, genetic engineering, protein chemistry, genomics and chemical engineering, have been successfully incorporated into the cell culture field. Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of types of media used in light of the new technologies, growing competition, and changing customer needs.

INTENDED AUDIENCE

This study contributes to the areas of market growth in the cell culture industry from the point of view of manufacturers and users. Biotechnological companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals, and research institutes will find this study to be of interest. SCOPE OF THE STUDY The scope of this study encompasses the biotechnology, pharmaceutical, and medical markets. BCC analyzes each market and its applications by its need for development of new medications through cell culture techniques, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this market research report. BCC conducted a comprehensive search of the literature, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various analytical/chemical/pharmaceutical/biotechnical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES

Many companies within the industry were contacted to obtain data for this study. Included were manufacturers and end users of biopharmaceutical and pharmaceutical companies through their production, research, and contract manufacturing/research lines. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.

ABOUT THE AUTHOR

Shalini S. Dewan holds a master's degree in pharmaceutical chemistry. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen to 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S.

Table of Contents

The Dynamic Media, Sera and Reagent Market in Biotechnology

Chapter- 1: INTRODUCTION -- Complimentary

  • STUDY OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • INTENDED AUDIENCE
  • SCOPE OF THE STUDY
  • METHODOLOGY
  • INFORMATION SOURCES
  • ABOUT THE AUTHOR
  • RELATED BCC RESEARCH REPORTS
  • BCC ONLINE SERVICES
  • DISCLAIMER

Chapter-2: EXECUTIVE SUMMARY

  • EXECUTIVE SUMMARY
  • SUMMARY TABLE MEDIA, SERA, AND REAGENT USED IN THE BIOTECHNOLOGY MARKET WORLDWIDE, THROUGH 2015 ($ MILLIONS)
  • SUMMARY FIGURE MEDIA, SERA, AND REAGENTS USED IN THE BIOTECHNOLOGY MARKET WORLDWIDE, 2008-2015 ($ MILLIONS)

Chapter-3: OVERVIEW

  • TABLE 1 HISTORICAL EVENTS IN CELL CULTURE DEVELOPMENT, 1878-1985
  • TABLE 1 (CONTINUED)
  • PRODUCTS FROM CELL CULTURE TECHNOLOGY
  • VIRAL VACCINES
    • TABLE 2 CULTURE MEDIA USED IN THE PRODUCTION OF VACCINES
    • TABLE 2 (CONTINUED)
  • RECOMBINANT THERAPEUTIC PROTEINS
  • Cytokines
  • Hematopoietic Growth Factors
  • Human Growth Hormones
  • Recombinant Thrombolytic Agents
    • TABLE 3 RECOMBINANT THROMBOLYTIC AGENTS
  • Recombinant Coagulation Factor
    • TABLE 4 RECOMBINANT COAGULATION FACTORS
  • MONOCLONAL ANTIBODIES (MABS)
  • TYPES OF CELL CULTURE
  • PRIMARY CELLS
  • SECONDARY CELLS
  • DIPLOID CELL STRAINS
  • CONTINUOUS CELL LINES
  • CONTAMINANTS OF CELL CULTURE
  • CHEMICAL CONTAMINANTS
  • BIOLOGICAL CONTAMINANTS
  • CELL CULTURE PRODUCTS
  • CELL CULTURE MEDIA
  • Basic Constituents of Media
  • Inorganic Salts
    • TABLE 5 THE ROLES OF DIFFERENT INORGANIC NUTRIENTS
  • Buffering Systems
  • Energy Source
  • Amino Acids
  • Vitamins
  • Proteins and Peptides
  • Fatty Acids and Lipids
  • Trace Elements
  • Antibiotics
    • TABLE 6 COMMONLY USED ANTIBIOTICS IN CELL CULTURE
    • TABLE 7 POTENTIAL SOURCES OF CELL CULTURE ADDITIVES
  • Serum
  • TYPES OF CELL CULTURE MEDIA
  • SELECTION OF CELL CULTURE MEDIA
  • SERUM-CONTAINING MEDIA
    • TABLE 8 ADVANTAGES AND DISADVANTAGES OF SERUM-CONTAINING MEDIA
    • TABLE 8 (CONTINUED)
  • SERUM-FREE MEDIA
    • TABLE 9 ADVANTAGES AND DISADVANTAGES OF SERUM-FREE MEDIA
    • TABLE 9 (CONTINUED)
  • CHEMICALLY DEFINED MEDIA
  • Amino Acids
  • Carbohydrates
  • Inorganic Salts
  • Vitamins
  • PROTEIN-FREE MEDIA
  • WHY USE SERUM-FREE MEDIA
  • SERUM-FREE MEDIA SUPPLEMENTS
  • Hormones
  • Transferrin
  • Lipids
  • Hydrolysates
  • SERUM
  • ROLE OF SERUM IN CELL CULTURE
  • CELL CULTURE REAGENTS
  • Amino Acids and Vitamins
  • Antibiotics and Antimyotics
  • Buffers
  • Cell Dissociation Agents
  • Growth Supplements

Chapter-4: REGULATORY ISSUES

  • APPROVALS
    • TABLE 10 APPROVALS OF BLAS FROM 2007 TO MARCH 2010
    • TABLE 10 (CONTINUED)
    • TABLE 10 (CONTINUED)
    • TABLE 10 (CONTINUED)
    • TABLE 10 (CONTINUED)
    • TABLE 10 (CONTINUED)
    • TABLE 10 (CONTINUED)
    • TABLE 10 (CONTINUED)
  • RECALLS
    • TABLE 11 RECALLED BLAS FROM 2007 TO MARCH 2010
    • TABLE 11 (CONTINUED)
    • TABLE 11 (CONTINUED)
  • BIOLOGICS ADMINISTRATIVE ACTIONS
  • CLINICAL TRIALS
    • TABLE 12 U.S. CLINICAL TRIALS IN THE CELL CULTURE INDUSTRY
    • TABLE 12 (CONTINUED)
    • TABLE 12 (CONTINUED)
    • TABLE 12 (CONTINUED)

Chapter-5: INDUSTRY STRUCTURE

  • MANUFACTURERS/PRODUCTS FOR MEDIA, SERA, AND REAGENTS USED IN BIOTECHNOLOGY
    • TABLE 13 LEADING MANUFACTURERS OF MEDIA
    • TABLE 13 (CONTINUED)
    • TABLE 13 (CONTINUED)
    • TABLE 13 (CONTINUED)
    • TABLE 13 (CONTINUED)
    • TABLE 14 LEADING MANUFACTURERS OF SERA
    • TABLE 14 (CONTINUED)
    • TABLE 15 LEADING MANUFACTURERS OF CYTOKINES AND GROWTH FACTORS
    • TABLE 15 (CONTINUED)
    • TABLE 15 (CONTINUED)
    • TABLE 16 LEADING MANUFACTURERS OF CELL DISSOCIATION REAGENTS
    • TABLE 16 (CONTINUED)
    • TABLE 17 LEADING MANUFACTURERS OF ANTIBIOTICS AND ANTIMYCOTICS USED IN CELL CULTURE
    • TABLE 18 LEADING MANUFACTURERS OF OTHER REAGENTS
    • TABLE 18 (CONTINUED)
  • MARKET SHARES OF INDUSTRY LEADERS
  • MEDIA
  • Serum-Free Media
    • TABLE 19 WORLDWIDE MARKET SHARES OF SERUM-FREE MEDIA, BY COMPANY 2009 (%)
    • FIGURE 1 WORLDWIDE MARKET SHARES OF SERUM-FREE MEDIA, BY COMPANY, 2009 (%)
  • Serum-Requiring/Containing Media
    • TABLE 20 WORLDWIDE MARKET SHARES OF SERUM-CONTAINING MEDIA, BY COMPANY 2009 (%)
    • FIGURE 2 WORLDWIDE MARKET SHARES OF SERUM-CONTAINING MEDIA, BY COMPANY, 2009 (%)
  • Powdered Media
    • TABLE 21 WORLDWIDE MARKET SHARES OF POWDERED MEDIA, 2009 (%)
    • FIGURE 3 WORLDWIDE MARKET SHARES OF POWDERED MEDIA, BY COMPANY, 2009 (%)
  • Liquid Media
    • TABLE 22 WORLDWIDE MARKET SHARES OF LIQUID MEDIA, BY COMPANY, 2009 (%)
    • FIGURE 4 WORLDWIDE MARKET SHARES OF LIQUID MEDIA, BY COMPANY, 2009 (%)
  • Classical Media
    • TABLE 23 WORLDWIDE MARKET SHARES OF CLASSICAL MEDIA, BY COMPANY, 2009 (%)
    • FIGURE 5 WORLDWIDE MARKET SHARES OF CLASSICAL MEDIA, BY COMPANY, 2009 (%)
  • Specialty Media
    • TABLE 24 WORLDWIDE MARKET SHARES OF SPECIALITY MEDIA, BY COMPANY, 2009 (%)
    • FIGURE 6 WORLDWIDE MARKET SHARES OF SPECIALITY MEDIA, BY COMPANY, 2009 (%)
  • SERA
  • Bovine Sera
    • TABLE 25 WORLDWIDE MARKET SHARES OF BOVINE SERA, BY COMPANY, 2009 (%)
    • FIGURE 7 WORLDWIDE MARKET SHARES OF BOVINE SERA, BY COMPANY, 2009 (%)
  • Other Sera
    • TABLE 26 WORLDWIDE MARKET SHARES OF OTHER SERA, BY COMPANY, 2009 (%)
    • FIGURE 8 WORLDWIDE MARKET SHARES OF OTHER SERA, BY COMPANY, 2009 (%)
  • REAGENTS
  • Biological Response Modifiers
    • TABLE 27 WORLDWIDE MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS, BY COMPANY, 2009 (%)
    • FIGURE 9 WORLDWIDE MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS, BY COMPANY, 2009 (%)
  • Cell Dissociation Reagents
    • TABLE 28 WORLDWIDE MARKET SHARES OF CELL DISSOCIATION REAGENTS, BY COMPANY, 2009 (%)
    • FIGURE 10 WORLDWIDE MARKET SHARES OF CELL DISSOCIATION REAGENTS, BY COMPANY, 2009 (%)
  • Other Reagents
    • TABLE 29 WORLDWIDE MARKET SHARES OF OTHER REAGENTS, BY COMPANY, 2009 (%)
    • FIGURE 11 WORLDWIDE MARKET SHARES OF OTHER REAGENTS BY COMPANY, 2009 (%)

Chapter-6: NEW DEVELOPMENTS

  • NEW DEVELOPMENTS
    • TABLE 30 NEW DEVELOPMENTS IN CELL CULTURE INDUSTRY SINCE 2007

Chapter-7: MARKETS

  • MEDIA
  • MARKET OVERVIEW
  • Market Overview (Continued)
  • MARKET REVENUE
    • TABLE 31 WORLDWIDE MARKET FOR MEDIA USED IN BIOTECHNOLOGY BY REGION, THROUGH 2015 ($ MILLIONS)
    • FIGURE 12 WORLDWIDE MARKET FOR MEDIA USED IN BIOTECHNOLOGY BY REGION, 2008-2015 ($ MILLIONS)
  • MARKET SHARES
    • TABLE 32 WORLDWIDE BIOTECHNOLOGY MEDIA MARKET SHARES, BY REGION, 2009 (%)
    • FIGURE 13 WORLDWIDE BIOTECHNOLOGY MEDIA MARKET SHARES, BY REGION, 2009 (%)
  • SERUM-FREE MEDIA AND SERUM-REQUIRING MEDIA
  • Serum-Free Media Market Revenue
    • TABLE 33 WORLDWIDE MARKET FOR SERUM-FREE MEDIA BY REGION, THROUGH 2015 ($ MILLIONS)
    • FIGURE 14 WORLDWIDE MARKET FOR SERUM-FREE MEDIA BY REGION, 2008-2015 ($ MILLIONS)
  • Serum-Requiring Media Market Revenue
    • TABLE 34 WORLDWIDE MARKET FOR SERUM-REQUIRING MEDIA BY REGION, THROUGH 2015 ($ MILLIONS)
    • FIGURE 15 WORLDWIDE MARKET FOR SERUM-REQUIRING MEDIA BY REGION, THROUGH 2015 ($ MILLIONS)
  • POWDERED MEDIA AND LIQUID MEDIA
  • Powdered Media Market Revenue
    • TABLE 35 WORLDWIDE MARKET FOR POWDERED MEDIA, BY REGION, THROUGH 2015 ($ MILLIONS)
    • FIGURE 16 WORLDWIDE MARKET FOR POWDERED MEDIA, BY REGION, 2008-2015 ($ MILLIONS)
  • Liquid Media Market Revenue
    • TABLE 36 WORLDWIDE MARKET FOR LIQUID MEDIA BY REGION, THROUGH 2015 ($ MILLIONS)
    • FIGURE 17 WORLDWIDE MARKET FOR LIQUID MEDIA, BY REGION, 2008-2015 ($ MILLIONS)
  • CLASSICAL AND SPECIALTY MEDIA
  • Classical Media Market Revenue
    • TABLE 37 WORLDWIDE MARKET FOR CLASSICAL MEDIA, BY REGION, THROUGH 2015 ($ MILLIONS)
    • FIGURE 18 WORLDWIDE MARKET FOR CLASSICAL MEDIA, BY REGION, 2008-2015 ($ MILLIONS)
  • Specialty Media Market Revenue
    • TABLE 38 WORLDWIDE MARKET FOR SPECIALITY MEDIA, BY REGION, THROUGH 2015 ($ MILLIONS)
    • FIGURE 19 WORLDWIDE MARKET FOR SPECIALITY MEDIA, BY REGION, 2008-2015 ($ MILLIONS)
  • SERA
  • MARKET OVERVIEW
  • MARKET REVENUE
    • TABLE 39 WORLDWIDE MARKET FOR SERA, BY REGION, THROUGH 2015 ($ MILLIONS)
    • FIGURE 20 WORLDWIDE MARKET FOR SERA, BY REGION, 2008-2015 ($ MILLIONS)
  • MARKET SHARES
    • TABLE 40 WORLDWIDE SERA MARKET SHARES, BY REGION, 2009 (%)
    • FIGURE 21 WORLDWIDE SERA MARKET SHARES BY REGION, 2009 (%)
  • BOVINE SERA OR FETAL BOVINE SERA
    • TABLE 41 WORLDWIDE MARKET FOR BOVINE SERA, BY REGION, THROUGH 2015 ($ MILLIONS)
    • FIGURE 22 WORLDWIDE MARKET FOR BOVINE SERA, BY REGION, THROUGH 2015 ($ MILLIONS)
  • OTHER SERA
    • TABLE 42 WORLDWIDE MARKET FOR OTHER SERA, BY REGION, THROUGH 2015 ($ MILLIONS)
    • FIGURE 23 WORLDWIDE MARKET FOR OTHER SERA, BY REGION, 2008-2015 ($ MILLIONS)
  • REAGENTS
  • MARKET OVERVIEW
  • Market Overview (Continued)
  • MARKET REVENUE
    • TABLE 43 WORLDWIDE MARKET FOR CELL CULTURE REAGENTS, BY REGION, THROUGH 2015 ($ MILLIONS)
    • FIGURE 24 WORLDWIDE MARKET FOR CELL CULTURE REAGENTS, BY REGION, THROUGH 2015 ($ MILLIONS)
  • MARKET SHARES
    • TABLE 44 WORLDWIDE CELL CULTURE REAGENT MARKET SHARES, BY REGION, 2009 (%)
    • FIGURE 25 WORLDWIDE CELL CULTURE REAGENT MARKET SHARES, BY REGION, 2009 (%)
  • BIOLOGICAL RESPONSE MODIFIERS
    • TABLE 45 WORLDWIDE MARKET FOR BIOLOGICAL RESPONSE MODIFIERS BY REGION, THROUGH 2015 ($ MILLIONS)
    • FIGURE 26 WORLDWIDE MARKET FOR BIOLOGICAL RESPONSE MODIFIERS, BY REGION, THROUGH 2015 ($ MILLIONS)
  • Growth Factors
    • TABLE 46 WORLDWIDE MARKET FOR GROWTH FACTORS, BY REGION, THROUGH 2015 ($ MILLIONS)
    • FIGURE 27 WORLDWIDE MARKET FOR GROWTH FACTORS, BY REGION, THROUGH 2015 ($ MILLIONS)
  • Cytokines
    • TABLE 47 WORLDWIDE MARKET FOR CYTOKINES, BY REGION, THROUGH 2015 ($ MILLIONS)
    • FIGURE 28 WORLDWIDE MARKET FOR CYTOKINES BY REGION, THROUGH 2015 ($ MILLIONS)
  • Other Biological Response Modifiers
    • TABLE 48 WORLDWIDE MARKET FOR OTHER BIOLOGICAL RESPONSE MODIFIERS, BY REGION, THROUGH 2015 ($ MILLIONS)
    • FIGURE 29 WORLDWIDE MARKET FOR OTHER BIOLOGICAL RESPONSE MODIFIERS, BY REGION, THROUGH 2015 ($ MILLIONS)
  • CELL DISSOCIATION REAGENTS
    • TABLE 49 WORLDWIDE MARKET FOR CELL DISSOCIATION REAGENTS, BY REGION, THROUGH 2015 ($ MILLIONS)
    • FIGURE 30 WORLDWIDE MARKET FOR CELL DISSOCIATION REAGENTS, BY REGION, 2008-2015 ($ MILLIONS)
  • OTHERS
    • TABLE 50 WORLDWIDE MARKET FOR OTHERS, BY REGION, THROUGH 2015 ($ MILLIONS)
    • FIGURE 31 WORLDWIDE MARKET FOR OTHERS, BY REGION, 2008-2015 ($ MILLIONS)

Chapter-8: END USERS

  • MARKET SHARE OF APPLICATIONS
    • TABLE 51 WORLDWIDE MEDIA, SERA, AND REAGENT MARKET SHARES, BY END USER, 2009 (%)
    • FIGURE 32 WORLDWIDE MEDIA, SERA, AND REAGENT MARKET SHARES, BY END USER, 2009 (%)
  • RESEARCH SEGMENT
  • RESEARCH SEGMENT (CONTINUED)
  • Market Revenue
    • TABLE 52 GLOBAL SALES OF MEDIA, SERA, AND REAGENTS IN THE RESEARCH SEGMENT, THROUGH 2015 ($ MILLIONS)
    • FIGURE 33 GLOBAL SALES OF MEDIA, SERA, AND REAGENTS IN THE RESEARCH SEGMENT, 2008-2015 ($ MILLIONS)
  • PRODUCTION SEGMENT
  • Market Revenue
    • TABLE 53 GLOBAL SALES OF MEDIA, SERA, AND REAGENTS IN THE PRODUCTION SEGMENT, THROUGH 2015 ($ MILLIONS)
    • FIGURE 34 GLOBAL SALES OF MEDIA, SERA, AND REAGENTS IN THE PRODUCTION SEGMENT, 2008-2015 ($ MILLIONS)
  • CONTRACT SEGMENT
  • CONTRACT SEGMENT (CONTINUED)
  • Market Revenue
    • TABLE 54 GLOBAL SALES OF MEDIA, SERA, AND REAGENTS IN THE CONTRACT SEGMENT, THROUGH 2015 ($ MILLIONS)
    • FIGURE 35 GLOBAL SALES OF MEDIA, SERA, AND REAGENTS IN THE CONTRACT SEGMENT, 2008-2015 ($ MILLIONS)
  • OTHERS SEGMENT
  • Market Revenue
    • TABLE 55 GLOBAL SALES OF MEDIA, SERA, AND REAGENTS IN THE OTHERS CATEGORY, THROUGH 2015 ($ MILLIONS)
    • FIGURE 36 GLOBAL SALES OF MEDIA, SERA, AND REAGENTS IN THE OTHERS CATEGORY, 2008-2015 ($ MILLIONS)

Chapter-9: PATENT ANALYSIS

  • PATENTS BY YEAR
    • TABLE 56 NUMBER OF SIGNIFICANT U.S. PATENTS FOR MEDIA, SERA, AND REAGENTS USED IN BIOTECHNOLOGY, BY YEAR, 2006 - 2010*
    • FIGURE 37 NUMBER OF U.S. PATENTS FOR MEDIA, SERA, AND REAGENTS USED IN BIOTECHNOLOGY BY YEAR, 2006 - 2010*
  • PATENTS BY TYPE
    • TABLE 57 U.S. PATENTS BY TYPE FOR MEDIA, SERA, AND REAGENTS USED IN BIOTECHNOLOGY, 2006 - 2010*
    • FIGURE 38 U.S. PATENTS BY TYPE FOR MEDIA, SERA, AND REAGENTS USED IN BIOTECHNOLOGY, 2006 - 2010*
  • PATENTS BY COMPANY
    • TABLE 58 NUMBER OF U.S. PATENTS BY COMPANY FOR MEDIA, SERA, AND REAGENTS IN BIOTECHNOLOGY, 2006 - 2010*
    • TABLE 58 (CONTINUED)
    • FIGURE 39 NUMBER OF U.S. PATENTS FOR MEDIA, SERA, AND REAGENTS USED IN BIOTECHNOLOGY, 2006 - 2010*
  • PATENTS BY COUNTRY
    • TABLE 59 NUMBER OF U.S. PATENTS BY COUNTRY FOR MEDIA, SERA, AND REAGENTS USED IN BIOTECHNOLOGY, 2006 - 2010*
    • FIGURE 40 NUMBER OF U.S. PATENTS BY COUNTRY FOR MEDIA, SERA, AND REAGENTS USED IN BIOTECHNOLOGY, 2006 - 2010*
    • TABLE 60 U.S. PATENT SHARES BY COUNTRY FOR MEDIA, SERA, AND REAGENTS USED IN BIOTECHNOLOGY, 2006 - 2010* (%)
    • FIGURE 41 U.S. PATENT SHARES BY COUNTRY FOR MEDIA, SERA, AND REAGENTS USED IN BIOTECHNOLOGY, 2006 - 2010
  • PATENTS BY ASSIGNEE
    • TABLE 61 U.S. PATENTS BY ASSIGNEE FOR MEDIA, SERA, AND REAGENTS USED IN BIOTECHNOLOGY, 2006 - 2010*
    • FIGURE 42 U.S. PATENTS BY ASSGINEE FOR MEDIA, SERA, AND REAGENTS USED IN BIOTECHNOLOGY, 2006 - 2010*

Chapter-10: CURRENT MARKET ENVIRONMENT

  • LEADING PLAYERS IN THE CELL CULTURE PRODUCTS MARKET
    • TABLE 62 LEADERS IN OVERALL CELL CULTURE MARKET, 2009 (%)
  • FACTORS AFFECTING THE MEDIA, SERA, AND REAGENTS MARKET
  • INCREASED DEMAND FOR BIOTHERAPEUTICS
  • INCREASED RESEARCH AND DEVELOPMENT BUDGET
  • INNOVATIONS
  • REGULATORY AND ETHICAL ISSUES
  • FUTURE OF CELL CULTURE MARKET
  • FUTURE OF CELL CULTURE MARKET (CONTINUED)
    • TABLE 63 CURRENT PRODUCT SHORTAGES

Chapter-11: COMPANY PROFILES

  • ADVANCED BIOTECHNOLOGIES, INC.
  • ATLANTA BIOLOGICALS, INC.
  • ATHENA ES
  • BD BIOSCIENCES
  • BIORECLAMATION, INC.
  • CELL APPLICATIONS, INC.
  • CLONTECH LABORATORIES, INC.
  • GEMINI BIO-PRODUCTS
  • IRVINE SCIENTIFIC
  • INVITROGEN CORP.
  • J R SCIENTIFIC, INC.
  • LONZA
  • MEDIATECH, INC.
  • MILLIPORE CORP.
  • PAA LABORATORIES
  • PEPROTECH, INC.
  • QULAITY BIOLOGICAL, INC.
  • R&D SYSTEMS
  • ROCHE APPLIED SCIENCES
  • SERACARE LIFE SCIENCES, INC.
  • SIGMA-ALDRICH
  • STEMCELL TECHNOLOGIES
  • THERMO FISHER SCIENTIFIC, INC.
  • TICO EUROPE
  • USB CORP.

APPENDIX I

  • APPENDIX I: ABBREVIATIONS
  • APPENDIX I (CONTINUED)
Back to Top